Loading…
Loading…
EQUITY / NASDAQ · XNCM
BioVie Inc.
01 / RESEARCH
8 financial reports are available for research.
Start research ↗1.555 USD · 2.3026%
Observed: Oct 1, 2026, 11:00 AM · TickerLayer indicative price; may be delayed
Powered by TickerLayer
09/30/2026 · 1.52 USD · Volume 201,349
251 actual observations · Latest bar: 2026-09-30 · Market data is indicative; provider terms apply.
8 available financial reports
Research reports →SEC FINANCIAL REPORTS
07/01/2025 – 06/30/2026 · Units
| Metric | 2026 / Year end | 2025 / Year end | Change |
|---|---|---|---|
| Cash and cash equivalents | 8,977,370 USD | 17,544,547 USD | -48.83% |
| Financing cash flow | 10,457,629 USD | 12,725,954 USD | -17.82% |
| Net income | -22,072,863 USD | -17,542,120 USD | — |
| Operating cash flow | -19,024,806 USD | -19,025,205 USD | — |
| Operating profit | -22,651,733 USD | -18,066,200 USD | — |
Changes are calculated only for matching period length, consolidation, currency, and scale. Percentages are not shown for zero or negative baselines.
Each column uses its report's scale. Check column headers before comparing different consolidation scopes and scales.
| Financial metric | 2026 / Year endConsolidatedUnits · USD | 2026 / Quarter 3ConsolidatedUnits · USD | 2026 / Quarter 3ConsolidatedUnits · USD | 2026 / Quarter 3ConsolidatedUnits · USD | 2026 / Quarter 2ConsolidatedUnits · USD | 2026 / Quarter 3ConsolidatedUnits · USD | 2025 / Year endConsolidatedUnits · USD | 2025 / Quarter 3ConsolidatedUnits · USD |
|---|---|---|---|---|---|---|---|---|
| Cash and cash equivalentsBalance sheet | 8,977,370 USD | 13,098,976 USD | — | — | — | — | 17,544,547 USD | 17,544,547 USD |
| Financing cash flowCash flow statement | 10,457,629 USD | — | 10,457,629 USD | — | 10,457,629 USD | — | 12,725,954 USD | — |
| Net incomeIncome statement | -22,072,863 USD | -5,270,299 USD | -16,427,331 USD | -6,069,475 USD | -11,157,032 USD | -5,087,557 USD | -17,542,120 USD | — |
| Operating cash flowCash flow statement | -19,024,806 USD | — | -14,903,200 USD | — | -7,461,591 USD | — | -19,025,205 USD | — |
| Operating profitIncome statement | -22,651,733 USD | -5,385,377 USD | -16,932,277 USD | — | -11,546,899 USD | — | -18,066,200 USD | — |
| Total assetsBalance sheet | 14,250,462 USD | 17,514,621 USD | — | — | — | — | 21,562,199 USD | 21,562,199 USD |
| Total equityBalance sheet | 10,270,270 USD | 15,607,592 USD | — | 19,265,034 USD | — | 24,921,004 USD | 19,011,985 USD | 19,011,985 USD |
| Total liabilitiesBalance sheet | 3,980,192 USD | 1,907,029 USD | — | — | — | — | 2,550,214 USD | 2,550,214 USD |
| Report source | Open report ↗ Published: 08/13/2026 | Open report ↗ Published: 05/11/2026 | Open report ↗ Published: 05/11/2026 | Open report ↗ Published: 05/11/2026 | Open report ↗ Published: 02/06/2026 | Open report ↗ Published: 05/11/2026 | Open report ↗ Published: 08/13/2026 | Open report ↗ Published: 05/11/2026 |
The latest available source version is shown for each period. Previous versions and correction relationships are not shown in this view.